Skip to content

Clinical trials

Arthritis, Rheumatoid trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arthritis, Rheumatoid Phase: Not applicable Clear all

603 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20018
20022
20037
200410
20058
20066
20079
200810
200920
201013
201117
201220
201330
201432
201518
201635
201732
201828
201933
202039
202139
202239
202337
202438
202542
202626

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed337
Unknown status107
Recruiting55
Terminated32
Active, not recruiting27
Not yet recruiting27
Withdrawn10
Enrolling by invitation6
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zimmer Biomet24
University Hospital, Montpellier13
Brigham and Women's Hospital10
DePuy Orthopaedics10
University Hospital, Clermont-Ferrand9
Duke University7
University of British Columbia7
Assistance Publique - Hôpitaux de Paris6
Diakonhjemmet Hospital6
Centre Hospitalier Universitaire de Saint Etienne5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis, Rheumatoid603
Osteoarthritis71
Arthritis63
Arthritis, Psoriatic35
Pain30
Osteonecrosis27
Inflammation22
Fatigue19
Lupus Erythematosus, Systemic19
Osteoarthritis, Knee17

Trials

Showing 76 to 100 of 603. Each trial links to its page on Pharma Observatory.

503 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.